HSP90B2P and atrial fibrillation: The findings will elucidate whether HSP levels and electrophysiological characteristics represent a novel diagnostic tool (a so-called “bio-electrical fingerprint”) to predict the clinical outcome for AF patients and/or cardiac surgery.